Follow
Abdullah Gandomkar
Abdullah Gandomkar
Non-communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Verified email at sums.ac.ir
Title
Cited by
Cited by
Year
Prevalence of chronic constipation and its associated factors in pars cohort study: a study of 9000 adults in Southern Iran
P Moezi, A Salehi, H Molavi, H Poustchi, A Gandomkar, MH Imanieh, ...
Middle East journal of digestive diseases 10 (2), 75, 2018
512018
Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results
A Gandomkar, H Poustchi, M Moini, M Moghadami, H Imanieh, MR Fattahi, ...
International journal of public health 62, 397-406, 2017
422017
Epidemiologic study of opium use in Pars Cohort Study: A study of 9000 adults in a rural southern area of Iran
MA Fallahzadeh, A Salehi, M Naghshvarian, MH Fallahzadeh, H Poustchi, ...
Archives of Iranian medicine 20 (4), 0-0, 2017
372017
Epidemiology of adult diabetes mellitus and its correlates in pars cohort study in Southern Iran
A Akbarzadeh, A Salehi, HM Vardanjani, H Poustchi, A Gandomkar, ...
Archives of Iranian medicine 22 (11), 633-639, 2019
232019
Prevalence, awareness, treatment, control, and correlates of hypertension in the pars cohort study
A Gandomkar, H Poustchi, F Malekzadeh, MM Malekzadeh, M Moini, ...
Archives of Iranian medicine 21 (8), 335-343, 2018
222018
Agreement between laboratory-based and non-laboratory-based Framingham risk score in Southern Iran
F Rezaei, M Seif, A Gandomkar, MR Fattahi, J Hasanzadeh
Scientific reports 11 (1), 10767, 2021
212021
The association between waterpipe smoking and gastroesophageal reflux disease
A Etemadi, A Gandomkar, ND Freedman, M Moghadami, MR Fattahi, ...
International Journal of Epidemiology 46 (6), 1968-1977, 2017
202017
Prevalence and correlates of Gastroesophageal reflux disease in southern Iran: pars cohort study
Z Khodamoradi, A Gandomkar, H Poustchi, A Salehi, MH Imanieh, ...
Middle East journal of digestive diseases 9 (3), 129, 2017
192017
Comparison of laboratory-based and non-laboratory-based WHO cardiovascular disease risk charts: a population-based study
F Rezaei, M Seif, A Gandomkar, MR Fattahi, F Malekzadeh, SG Sepanlou, ...
Journal of Translational Medicine 20 (1), 133, 2022
182022
Estimation of 10-year risk of cardiovascular diseases using WHO risk prediction charts: A population-based study in Southern Iran
F Rezaei, M Seif, MR Fattahi, A Gandomkar, J Hasanzadeh
Iranian Journal of Public Health 51 (7), 1667, 2022
52022
Upper normal limit of serum alanine aminotransferase and its association with metabolic risk factors in pars cohort study
F Sehatpour, A Salehi, HM Vardanjani, H Poustchi, A Gandomkar, ...
Middle East Journal of Digestive Diseases 12 (1), 19, 2020
32020
Pictogram is a valid instrument to classify at-risk adult population based on abdominal obesity: results from Pars Cohort Study
A Kamalipour, A Roshanshad, M Nalini, J Hassanzadeh, R Malekzadeh, ...
Archives of Iranian Medicine 25 (6), 366-374, 2022
22022
Effectiveness of polypill for prevention of cardiovascular disease (PolyPars): Protocol of a randomized controlled trial
F Malekzadeh, A Gandomkar, Z Malekzadeh, H Poustchi, M Moghadami, ...
Archives of Iranian Medicine 23 (8), 548-556, 2020
22020
Prevalence and Correlates of Polypharmacy, and Drug Utilization Pattern in a Semi-urban Population: Results from the Pars Cohort Study
MR Akbari, A Kamalipour, M Pakroo, B Mesgarpour, H Poustchi, ...
Archives of Iranian medicine 26 (3), 156, 2023
12023
Validity of body image pictogram to determine overweight/obesity in adults from less developed populations: results from pars cohort study
S Bazdar, MH Sharifi, H Puostchi, A Gandomkar, R Malekzadeh, ...
Archives of Iranian medicine 25 (12), 779, 2022
12022
The pattern of medication use, and determinants of the prevalence of polypharmacy among patients with a recent history of depressive disorder: results from the pars cohort study
M Ghaed-Sharaf, S Hariri, H Poustchi, M Nourollahi, S Khani, E Taherifard, ...
BMC psychology 10 (1), 12, 2022
12022
Prevalence of Hepatitis B and C infections and associated risk factors in Pars cohort study, Southern Iran
S Hariri, S Davari, Z Malekzadeh, Z Mohammadi, S Masoudi, ...
Middle East Journal of Digestive Diseases 13 (2), 95, 2021
12021
Correction: Effectiveness of Polypill for Prevention of Cardiovascular Disease (PolyPars): Protocol of a Randomized Controlled Trial.
F Malekzadeh, A Gandomkar, Z Malekzadeh, H Poustchi, M Moghadami, ...
Archives of Iranian Medicine 24 (2), 166-166, 2021
12021
Effectiveness of polypill for primary and secondary prevention of cardiovascular disease: a pragmatic cluster-randomised controlled trial (PolyPars)
F Malekzadeh, A Gandomkar, H Poustchi, A Etemadi, G Roshandel, ...
Heart, 2024
2024
Prevalence of metabolically healthy obesity and healthy overweight and the associated factors in southern Iran: A population‐based cross‐sectional study
E Taherifard, E Taherifard, M Jeddi, A Ahmadkhani, R Kelishadi, ...
Health Science Reports 7 (2), e1909, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20